683 results on '"Baek,Sang-Hong"'
Search Results
2. Eligibility and Cost-Utility Analysis of Dapagliflozin in Patients with Heart Failure Across the Whole Spectrum of Ejection Fraction in South Korea
3. Metformin treatment is associated with improved survival in diabetic patients hospitalized with acute heart failure: A prospective observational study using the Korean acute heart failure registry data
4. Author Correction: Pharmacological inhibition of mTOR attenuates replicative cell senescence and improves cellular function via regulating the STAT3-PIM1 axis in human cardiac progenitor cells
5. Author Correction: Human cardiac stem cells rejuvenated by modulating autophagy with MHY-1685 enhance the therapeutic potential for cardiac repair
6. In-hospital glycemic variability and all-cause mortality among patients hospitalized for acute heart failure
7. Polygenic Risk Scores for Atherosclerotic Cardiovascular Disease in the Asia-Pacific Region
8. Human cardiac stem cells rejuvenated by modulating autophagy with MHY-1685 enhance the therapeutic potential for cardiac repair
9. Response to beta-blockers and natriuretic peptide level in acute heart failure: analysis of data from the Korean acute heart failure registry
10. Predicting survival in heart failure: a risk score based on machine-learning and change point algorithm
11. Tackling cardiometabolic risk in the Asia Pacific region
12. Real-World Eligibility and Cost-Effectiveness Analysis of Empagliflozin for Heart Failure in Korea
13. Clinical impact of statin therapy on vasospastic angina: data from a Korea nation-wide cohort study
14. Engineered M13 Peptide Carrier Promotes Angiogenic Potential of Patient-Derived Human Cardiac Progenitor Cells and In Vivo Engraftment
15. Pharmacological inhibition of mTOR attenuates replicative cell senescence and improves cellular function via regulating the STAT3-PIM1 axis in human cardiac progenitor cells
16. Impact of insulin therapy on the mortality of acute heart failure patients with diabetes mellitus
17. Admission serum potassium levels and prognosis of vasospastic angina
18. Effects of sarcopenia, body mass indices, and sarcopenic obesity on diastolic function and exercise capacity in Koreans
19. Impact of multi-vessel vasospastic angina on cardiovascular outcome
20. Outcomes After Predischarge Initiation of β-Blocker in Patients Hospitalized for Severe Decompensated Heart Failure Requiring Inotropic Therapy
21. Effect of renin-angiotensin system blockade in patients with severe renal insufficiency and heart failure
22. Efficacy and Safety of Fixed-dose Combination Therapy With Telmisartan and Rosuvastatin in Korean Patients With Hypertension and Dyslipidemia: TELSTA-YU (TELmisartan-rosuvaSTAtin from YUhan), a Multicenter, Randomized, 4-arm, Double-blind, Placebo-controlled, Phase III Study
23. Effects of angiotensin receptor blocker at discharge in patients with heart failure with reduced ejection fraction: Korean Acute Heart Failure (KorAHF) registry
24. The Effect of Door-to-Diuretic Time on Clinical Outcomes in Patients With Acute Heart Failure
25. Correction to: Predicting survival in heart failure: a risk score based on machine-learning and change point algorithm
26. Clinical outcome according to spasm type of single coronary artery provoked by intracoronary ergonovine tests in patients without significant organic stenosis
27. Short and long-term prognostic value of hyponatremia in heart failure with preserved ejection fraction versus reduced ejection fraction: An analysis of the Korean Acute Heart Failure registry
28. Reverse J-Curve Relationship Between On-Treatment Blood Pressure and Mortality in Patients With Heart Failure
29. Sex differences in clinical characteristics and long-term outcomes in patients with vasospastic angina: results from the VA-Korea registry, a prospective multi-center cohort
30. Impact of diabetes mellitus on mortality in patients with acute heart failure: a prospective cohort study
31. Coronary Plaque Characteristics and Cut-Off Stenosis for Developing Spasm in Patients with Vasospastic Angina
32. Impact of Overweight/Obesity on Clinical Outcomes of Patient with Vasospastic Angina: From the Vasospastic Angina in Korea Registry
33. Relationship between airflow obstruction and coronary atherosclerosis in asymptomatic individuals: evaluation by coronary CT angiography
34. Engineered M13 Peptide Carrier Promotes Angiogenic Potential of Patient-Derived Human Cardiac Progenitor Cells and In VivoEngraftment
35. Clopidogrel plus Aspirin Use is Associated with Worse Long-Term Outcomes, but Aspirin Use Alone is Safe in Patients with Vasospastic Angina: Results from the VA-Korea Registry, A Prospective Multi-Center Cohort
36. The 24-Month Prognosis of Patients With Positive or Intermediate Results in the Intracoronary Ergonovine Provocation Test
37. Additional file 5 of In-hospital glycemic variability and all-cause mortality among patients hospitalized for acute heart failure
38. Additional file 2 of In-hospital glycemic variability and all-cause mortality among patients hospitalized for acute heart failure
39. Additional file 4 of In-hospital glycemic variability and all-cause mortality among patients hospitalized for acute heart failure
40. Additional file 1 of In-hospital glycemic variability and all-cause mortality among patients hospitalized for acute heart failure
41. Additional file 3 of In-hospital glycemic variability and all-cause mortality among patients hospitalized for acute heart failure
42. C-reactive protein and statins in heart failure with reduced and preserved ejection fraction
43. Skin penetration-inducing gelatin methacryloyl nanogels for transdermal macromolecule delivery
44. Regulation of ROS-independent ERK signaling rescues replicative cellular senescence in ex vivo expanded human c-kit-positive cardiac progenitor cells
45. Amine-enriched surface modification facilitates expansion, attachment, and maintenance of human cardiac-derived c-kit positive progenitor cells
46. Abstract 21002: Comparison of Clinical Outcomes of Patients With Acute Heart Failure and Recovered Ejection Fraction versus Preserved or Reduced Ejection Fraction
47. Short-term use of telmisartan attenuates oxidation and improves Prdx2 expression more than antioxidant β-blockers in the cardiovascular systems of spontaneously hypertensive rats
48. Modified reverse shock index predicts early outcomes of heart failure with reduced ejection fraction
49. Nitrates vs. Other Types of Vasodilators and Clinical Outcomes in Patients with Vasospastic Angina: A Propensity Score-Matched Analysis
50. Impact of successful restoration of sinus rhythm in patients with atrial fibrillation and acute heart failure: Results from the Korean Acute Heart Failure registry
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.